Clinical Trial Detail

NCT ID NCT02208037
Title Novel Approaches for Graft-versus-Host Disease Prevention Compared to Contemporary Controls (BMT CTN 1203)
Recruitment Completed
Gender both
Phase Phase II
Variant Requirements no
Sponsors National Heart, Lung, and Blood Institute (NHLBI)
Indications

acute leukemia

mantle cell lymphoma

chronic myeloid leukemia

diffuse large B-cell lymphoma

follicular lymphoma

marginal zone B-cell lymphoma

chronic lymphocytic leukemia

Hodgkin's lymphoma

Therapies
Age Groups: adult

No variant requirements are available.